Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Embecta Corp. (EMBC : NSDQ)

• Company Description    Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J. Number of Employees: 2,100

• Price / Volume Information    Yesterday's Closing Price: $10.47 Daily Weekly Monthly 20 Day Moving Average: 639,504 shares Shares Outstanding: 58.44 (millions) Market Capitalization: $611.89 (millions) Beta: 1.08 52 Week High: $21.48 52 Week Low: $9.20 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 9.52% 4.57% 12 Week -7.67% -22.08% Year To Date -49.30% -52.36%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 300 Kimball Drive - Parsippany,NJ 07054 USA ph: 862-401-0000 fax: - investor.relations@embecta.com http://www.embecta.com

• General Corporate Information    Officers Devdatt Kurdikar - President and Chief Executive Officer David F. Melcher - Chairman Jacob Elguicze - Senior Vice President; Chief Financial Officer David J. Albritton - Director Carrie L. Anderson - Director Peer Information Embecta Corp. (CHCR) Embecta Corp. (ESRX) Embecta Corp. (MYDP) Embecta Corp. (COR) Embecta Corp. (GBCS) Embecta Corp. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 29082K105 SIC: 3841 Fiscal Year Fiscal Year End: September Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/08/25 Share - Related Items Shares Outstanding: 58.44 Most Recent Split Date: (:1) Beta: 1.08 Market Capitalization: $611.89 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 5.73% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.60 Current Fiscal Year EPS Consensus Estimate: $2.81 Payout Ratio: 0.24 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 5.54% Last Dividend Paid: 05/28/2025 - $0.15 Next EPS Report Date: 08/08/25

• Fundamental Ratios P/E Current FY Estimate: 3.73 Trailing 12 Months: 4.12 PEG Ratio: 0.67 Price Ratios Price/Book: - Price/Cash Flow: 3.14 Price / Sales: 0.57 EPS Growth vs. Year Ago Period: 4.48% vs. Previous Quarter: 7.69% Sales Growth vs. Year Ago Period: -9.82% vs. Previous Quarter: -1.11% ROE 06/30/25 - - 03/31/25 - -19.67 12/31/24 - -19.22 ROA 06/30/25 - - 03/31/25 - 12.27 12/31/24 - 11.92 Current Ratio 06/30/25 - - 03/31/25 - 2.48 12/31/24 - 2.24 Quick Ratio 06/30/25 - - 03/31/25 - 1.83 12/31/24 - 1.67 Operating Margin 06/30/25 - - 03/31/25 - 13.70 12/31/24 - 13.19 Net Margin 06/30/25 - - 03/31/25 - 4.89 12/31/24 - 5.25 Pre-Tax Margin 06/30/25 - - 03/31/25 - 5.10 12/31/24 - 2.64 Book Value 06/30/25 - - 03/31/25 - -12.66 12/31/24 - -13.23 Inventory Turnover 06/30/25 - - 03/31/25 - 2.27 12/31/24 - 2.36 Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©